APPLICATION
ANDA075046
TYPE
ANDA
ORIGINAL APPROVAL
1998-08-12
LATEST ACTION
2025-12-22
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
BUTORPHANOL TARTRATEPrescription
BUTORPHANOL TARTRATE 2MG/ML · INJECTABLE · INJECTION
Approval history
2025-12-22Labeling · Supplement 16 · standardAP
2024-01-10Labeling · Supplement 15 · standardAP
2024-01-10Labeling · Supplement 14 · standardAP
2019-10-11Labeling · Supplement 13 · standardAP
2001-10-30Labeling · Supplement 3AP
2001-04-03Manufacturing (CMC) · Supplement 2AP
1999-10-15Labeling · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.